Eledon Pharmaceuticals In... (ELDN)
NASDAQ: ELDN
· Real-Time Price · USD
2.63
0.03 (1.15%)
At close: Aug 15, 2025, 3:59 PM
2.63
0.19%
After-hours: Aug 15, 2025, 07:54 PM EDT
Eledon Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -32.38M | -36.18M | -1.19M | -75.18M | -39.85M | -40.33M | -89.08M | -89.21M | -88.87M | -87.97M | -38.39M | -37.73M | -35.87M | -34.51M | -31.6M | -27.93M | -23.13M |
Depreciation & Amortization | 264K | 359K | 365K | 380K | 377K | 374K | 373K | 372K | 372K | 373K | 341K | 292K | 242K | 195K | 179K | 181K | 183K |
Stock-Based Compensation | 14.29M | 13.12M | 8.25M | 8.2M | 6.86M | 6.54M | 6.31M | 6.76M | 7.35M | 8.15M | 8.73M | 8.59M | 8.32M | 7.9M | 7.51M | 6.34M | 4.51M |
Other Working Capital | -9.08M | -9.27M | -10.48M | -1.75M | -2.9M | -1.69M | -3.39M | -1.44M | 5K | -183K | -871K | -257K | -3.48M | -4.51M | -5.22M | -1.89M | -1.01M |
Other Non-Cash Items | -22.55M | -21.62M | -41.83M | 30.28M | -2.26M | -606K | 47.78M | 48.97M | 52.83M | 54.02M | 7.38M | 8.68M | 10.28M | 6.15M | 4.13M | -2.77M | -6.5M |
Deferred Income Tax | 431K | 431K | -889K | 363K | 1.99M | -597K | 292K | -418K | -4.18M | -1.59M | -2.17M | -3.4M | -1.85M | -2.35M | -2.18M | 4.65M | 5.24M |
Change in Working Capital | -1.78M | -1.52M | -685K | -508K | -4.03M | -4.92M | -5.54M | 1.33M | 2.31M | 2.37M | 1.74M | -557K | -2.74M | -152K | -3.04M | 292K | 1.17M |
Operating Cash Flow | -54.59M | -47.27M | -37.41M | -37.9M | -38.34M | -39.53M | -39.88M | -32.2M | -30.19M | -28.42M | -28.15M | -30.67M | -31.9M | -28.91M | -29.14M | -22.61M | -18.18M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.04K | 11.04K |
Purchase of Investments | -175.06M | -156.13M | -101.27M | -97.18M | -91.2M | -78.29M | -60.36M | -30.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 98.86M | 85.82M | 88.42M | 72.1M | 55.7M | 33M | 5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 9.78M | 9.79M | 9.77M | 9.74M | -45.29K | -55.36K | -30.33K | n/a | n/a | n/a | n/a | n/a | n/a | 11.04M | 11.04M | 11.04M |
Investing Cash Flow | -76.2M | -70.31M | -12.86M | -25.08M | -35.5M | -45.29M | -55.36M | -30.33M | n/a | n/a | n/a | n/a | n/a | n/a | 11.04M | 11.05M | 11.05M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 330K | 215K | -33.02K | -33.02K | -33.02K | -33.02K | n/a | n/a | n/a | n/a | -451K | -450K | -450K | -900K | -285K | 94.94M | 94.94M |
Financial Cash Flow | 133.64M | 133.52M | 53.35M | 48.07M | 33.02M | 33.02M | 33.02M | 33.02M | n/a | n/a | -450K | -449K | -449K | -899K | 8.71M | 103.94M | 103.94M |
Net Cash Flow | 2.84M | 15.94M | 3.08M | -14.91M | -40.83M | -51.8M | -62.22M | -29.51M | -30.19M | -28.42M | -28.15M | -30.67M | -31.9M | -29.36M | -20.42M | 92.37M | 96.79M |
Free Cash Flow | -54.59M | -47.27M | -37.41M | -37.9M | -38.34M | -39.53M | -39.88M | -32.2M | -30.19M | -28.42M | -28.15M | -30.67M | -31.9M | -28.91M | -29.14M | -22.61M | -18.18M |